Alon Ben-Noon, CEO of NeuroSense Therapeutics NRSN, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $200K. The latest trade was on 06/16.

AB

AB

Alon Ben-Noon

CEO

Company

NeuroSense Therapeutics NRSN

First filing

26/06/17

Trades

1 trades

Buys / sales

1 / 0

12-month net buying

$200K

Last trade

06/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
NeuroSense TherapeuticsNRSN	Open-market buy	06/16	06/17	250,000 sh	$0.80	$200,000	+5.8%